Keyphrases
Salmonella Enterica Serovar Typhimurium (S. Typhimurium)
100%
Vaccine Candidate
100%
Nonhuman Primate
100%
Tolerability
100%
Simian Immunodeficiency Virus
100%
Live Attenuated
28%
Vaccine Strain
28%
Live Attenuated Vaccine
28%
Non-typhoidal Salmonella
28%
Systemic Spread
28%
Fatality
14%
Vaccination
14%
Macrophages
14%
Wild Strain
14%
Neutrophils
14%
Sub-Saharan Africa
14%
Infiltration
14%
Nonhuman Primate Model
14%
Rhesus Macaque
14%
Natural Infection
14%
Clinical Parameters
14%
Common Cause
14%
Disease Manifestations
14%
Immunocompromised Host
14%
Young Infants
14%
Disease Incidence
14%
Cell Infiltration
14%
Digestive Tract
14%
High Resistance
14%
Intestinal Permeability
14%
Rhesus Macaque Model
14%
Systemic Disease
14%
Disease-specific Mortality
14%
Multidrug Resistance
14%
Attenuated S. Typhimurium
14%
Immunocompromised Subjects
14%
Salmonella Serovars
14%
Food-borne Gastroenteritis
14%
Intestinal Epithelial Damage
14%
Mucosal Permeability
14%
Pharmacology, Toxicology and Pharmaceutical Science
Salmonella Enterica Serovar Typhimurium
100%
Tolerability
100%
Simian Immunodeficiency Virus
100%
Vaccine Strain
28%
Live Vaccine
28%
Salmonella
28%
Rhesus Monkey
28%
Diseases
28%
Infection
14%
Case Fatality Rate
14%
Immunocompromised Patient
14%
Gastroenteritis
14%
Systemic Disease
14%
Multidrug Resistance
14%
Immunology and Microbiology
Salmonella Enterica Serovar Typhimurium
100%
Simian Immunodeficiency Virus
100%
Wild Type
42%
Attenuated Vaccine
28%
Live Vaccine
28%
Rhesus Monkey
28%
Salmonella
28%
Macrophage
14%
Neutrophil
14%
Case Fatality Rate
14%
Immunocompromised Patient
14%
Gastroenteritis
14%
Digestive System
14%
Multidrug Resistance
14%
Infection
14%